HomeCompareDNVVF vs ADC

DNVVF vs ADC: Dividend Comparison 2026

DNVVF yields 400.00% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DNVVF wins by $11437.65M in total portfolio value
10 years
DNVVF
DNVVF
● Live price
400.00%
Share price
$0.50
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11437.82M
Annual income
$7,667,192,697.76
Full DNVVF calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — DNVVF vs ADC

📍 DNVVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDNVVFADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DNVVF + ADC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DNVVF pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DNVVF
Annual income on $10K today (after 15% tax)
$34,000.00/yr
After 10yr DRIP, annual income (after tax)
$6,517,113,793.10/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, DNVVF beats the other by $6,517,045,115.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DNVVF + ADC for your $10,000?

DNVVF: 50%ADC: 50%
100% ADC50/50100% DNVVF
Portfolio after 10yr
$5719.00M
Annual income
$3,833,636,747.53/yr
Blended yield
67.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

DNVVF
No analyst data
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DNVVF buys
0
ADC buys
0
No recent congressional trades found for DNVVF or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDNVVFADC
Forward yield400.00%4.13%
Annual dividend / share$2.00$3.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$11437.82M$178.9K
Annual income after 10y$7,667,192,697.76$80,797.29
Total dividends collected$11090.87M$156.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: DNVVF vs ADC ($10,000, DRIP)

YearDNVVF PortfolioDNVVF Income/yrADC PortfolioADC Income/yrGap
1← crossover$50,700$40,000.00$10,990$580.36+$39.7KDNVVF
2$243,782$189,532.71$12,301$860.26+$231.5KDNVVF
3$1,112,560$851,713.55$14,104$1,298.62+$1.10MDNVVF
4$4,823,161$3,632,721.39$16,691$2,008.16+$4.81MDNVVF
5$19,879,046$14,718,264.42$20,580$3,205.09+$19.86MDNVVF
6$77,964,520$56,693,940.88$26,754$5,330.02+$77.94MDNVVF
7$291,226,244$207,804,207.46$37,196$9,345.14+$291.19MDNVVF
8$1,037,056,355$725,444,273.70$56,244$17,523.09+$1037.00MDNVVF
9$3,523,955,262$2,414,304,962.28$94,286$35,736.21+$3523.86MDNVVF
10$11,437,824,828$7,667,192,697.76$178,949$80,797.29+$11437.65MDNVVF

DNVVF vs ADC: Complete Analysis 2026

DNVVFStock

DEINOVE SA, a biotech company, discovers, develops, and produces compounds originating from microbials for the health, nutrition, and cosmetics industries worldwide. The company's antibiotic candidates include DNV3837, an antibiotic, which is in the Phase II clinical trial for the treatment of Clostridioides difficile infections. It also offers PHYT-N-Resist, an anti-aging active ingredient for cosmetics; Luminity, a carotenoid-based ingredient to absorb blue light and exceptional antioxidant properties; HEBELYS, a natural active ingredient produced by fermentation of Sphingomonas; and BIOME Oléoactif, which acts as a post-biotic extract with a prebiotic effect to balance the skin microbiota. In addition, the company develops a process for producing natural ingredients for animal feed. DEINOVE SA has partnership agreements primarily with bioMérieux, Naicons, Medpace, Institut Pasteur, Hallstar Group, Sharon Laboratories, Oléos-Hallstar, Greentech, and Avril. The company was founded in 2006 and is headquartered in Grabels, France.

Full DNVVF Calculator →

ADCREIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this DNVVF vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DNVVF vs SCHDDNVVF vs JEPIDNVVF vs ODNVVF vs KODNVVF vs MAINDNVVF vs NNNDNVVF vs EPRTDNVVF vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.